Han Op 'T Land Email & Phone Number

Weesp, Nh, Nl

Amsterdam, North Holland, Netherlands

Amsterdam

The QP responsibilities include Batch release, Improvement in work processes and involvement in the typical Quality areas: Change Control, CAPA, Complaint management, management of Quality issues.As portfolio manager responsible for developing and sustaining relations with partner companies.Additional responsibilities include qualification of and auditing at contract manufacturers and contract laboratories. Additionally giving technical input in process improvement projects.

Amsterdam

The primary responsibilities include Batch release, building and maintaining the Quality System, guiding improvements in work processes, auditing and qualification of suppliers and contractors and setting up of Quality agreements. Additional responsibilities include assessment of chemical, analytical and pharmaceutical information of existing and potential new products

Olst

This position was applied for to reconnect with the world of quality management in a production environment.Assignments included Supplier qualification, Quality agreements, Regulatory Compliance and management of cold chain transports

Position in knowledge Management and Innovation.Function to be seen as "knowledge broker" between internal parties in R&D but also between internal knowledge clients and external parties like universities or CROs.Responsibilities include introducing Knowledge management awareness and systems in projects and departments and supporting the organisation with tools like Communities of Practice, Knowledge Mapping etc.

Position in knowledge Management and Innovation.Function to be seen as "knowledge broker" between internal parties in R&D but also between internal knowledge clients and external parties like universities or CROs

Heading development of earliest formulations for preclinical up to and including Clin IDevising development approach for non BCS_1 compoundsQualificication of lab for support of GLP-studiesSetting up a training scheme to bridge the gap between research and early developmentDevising a strategy to shorten development timelinesDevising strategy for integrated outsourcing of early development and part of the preclinical work

Changing the department from technology oriented to client orientedIntroduction of a risk-based quality regime in this development environment

Managing and restructuring Quality Control LabPreparation for FDA-inspection (successful, end 1993)Restructuring method transfer from development departmentsRationalisation of (intermediate) product specification setting

Leading analytical support group teaming up with pharmaceutical development. Hot items at that time were:- introduction of method development strategies - standardized approach of method validation- risk based specification setting for residual solvents - introduction of robots in the laboratory environment